SPOTLIGHT -
Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.
Histamine: Psychiatry’s Neglected Monoamine
Treating ‘Morally Objectionable’ Patients
DBS: A Solution to Treatment-Resistant Schizophrenia
What Will the Future of Alzheimer Disease Treatment Look Like?
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder
Phase 3 SOLARIS Trial Demonstrates Potential of TEV-‘749 in Schizophrenia